Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis

Ann Rheum Dis. 2017 Nov;76(11):1915-1923. doi: 10.1136/annrheumdis-2017-211300. Epub 2017 Aug 11.

Abstract

Objective: The pathogenetic mechanisms by which HLA-DRB1 alleles are associated with anticitrullinated peptide antibody (ACPA)-positive rheumatoid arthritis (RA) are incompletely understood. RA high-risk HLA-DRB1 alleles are known to share a common motif, the 'shared susceptibility epitope (SE)'. Here, the electropositive P4 pocket of HLA-DRB1 accommodates self-peptide residues containing citrulline but not arginine. HLA-DRB1 His/Phe13β stratifies with ACPA-positive RA, while His13βSer polymorphisms stratify with ACPA-negative RA and RA protection. Indigenous North American (INA) populations have high risk of early-onset ACPA-positive RA, whereby HLA-DRB1*04:04 and HLA-DRB1*14:02 are implicated as risk factors for RA in INA. However, HLA-DRB1*14:02 has a His13βSer polymorphism. Therefore, we aimed to verify this association and determine its molecular mechanism.

Methods: HLA genotype was compared in 344 INA patients with RA and 352 controls. Structures of HLA-DRB1*1402-class II loaded with vimentin-64Arg59-71, vimentin-64Cit59-71 and fibrinogen β-74Cit69-81 were solved using X-ray crystallography. Vimentin-64Cit59-71-specific and vimentin59-71-specific CD4+ T cells were characterised by flow cytometry using peptide-histocompatibility leukocyte antigen (pHLA) tetramers. After sorting of antigen-specific T cells, TCRα and β-chains were analysed using multiplex, nested PCR and sequencing.

Results: ACPA+ RA in INA was independently associated with HLA-DRB1*14:02. Consequent to the His13βSer polymorphism and altered P4 pocket of HLA-DRB1*14:02, both citrulline and arginine were accommodated in opposite orientations. Oligoclonal autoreactive CD4+ effector T cells reactive with both citrulline and arginine forms of vimentin59-71 were observed in patients with HLA-DRB1*14:02+ RA and at-risk ACPA- first-degree relatives. HLA-DRB1*14:02-vimentin59-71-specific and HLA-DRB1*14:02-vimentin-64Cit59-71-specific CD4+ memory T cells were phenotypically distinct populations.

Conclusion: HLA-DRB1*14:02 broadens the capacity for citrullinated and native self-peptide presentation and T cell expansion, increasing risk of ACPA+ RA.

Keywords: T cells; autoimmunity; rheumatoid arthritis.

MeSH terms

  • Alaska / ethnology
  • Alaska Natives / genetics*
  • Alleles
  • Arginine / genetics
  • Arginine / immunology
  • Arthritis, Rheumatoid / ethnology*
  • Arthritis, Rheumatoid / genetics*
  • Autoantibodies / blood
  • Autoantibodies / immunology
  • CD4-Positive T-Lymphocytes / immunology
  • Canada / ethnology
  • Case-Control Studies
  • Citrulline / genetics
  • Citrulline / immunology
  • Female
  • Flow Cytometry
  • Genetic Predisposition to Disease / ethnology*
  • Genotype
  • HLA-DRB1 Chains / genetics*
  • Humans
  • Indians, North American / genetics*
  • Male
  • Peptides, Cyclic / immunology
  • Polymorphism, Genetic
  • Risk Factors
  • Vimentin / genetics

Substances

  • Autoantibodies
  • HLA-DRB1 Chains
  • Peptides, Cyclic
  • Vimentin
  • cyclic citrullinated peptide
  • Citrulline
  • Arginine